University Of Vermont Medical Center Dialysis South Burlington is a medicare approved dialysis facility center in South Burlington, Vermont and it has 18 dialysis stations. It is located in Chittenden county at 35 Joy Drive, South Burlington, VT, 05403. You can reach out to the office of University Of Vermont Medical Center Dialysis South Burlington at (802) 847-3030. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. University Of Vermont Medical Center Dialysis South Burlington has the following ownership type - Non-Profit. It was first certified by medicare in May, 2000. The medicare id for this facility is 473503 and it accepts patients under medicare ESRD program.
| Name | University Of Vermont Medical Center Dialysis South Burlington |
|---|---|
| Location | 35 Joy Drive, South Burlington, Vermont |
| No. of Dialysis Stations | 18 |
| Medicare ID | 473503 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | Yes |
| 35 Joy Drive, South Burlington, Vermont, 05403 | |
| (802) 847-3030 | |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
| NPI Number | 1013953280 |
| Doing Business As | University Of Vermont Medical Center Inc |
| Address | 35 Joy Dr S Burlington, Vermont, 05403 |
| Phone Number | (802) 847-0000 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 54% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 26% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 20% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 45% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 38% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 14% |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 64% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 24% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 12% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 73% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 12% |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 77% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 23% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 80% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 86 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 28 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 102 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 816 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 28 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 185 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 74 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at University Of Vermont Medical Center Dialysis South Burlington with elevated calcium levels.
| Patients with hypercalcemia | 142 |
| Hypercalcemia patient months | 1166 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 148 |
| Patients with Serumphosphor less than 3.5 mg/dL | 3 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 28 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 133 |
| Patient months included in arterial venous fistula and catheter summaries | 810 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 60 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 19 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 122 |
| Hospitalization Rate in facility | 107.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 191.8 |
| Hospitalization Rate: Lower Confidence Limit | 65.6 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at University Of Vermont Medical Center Dialysis South Burlington were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 24.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 37.4 |
| Readmission Rate: Lower Confidence Limit | 15.1 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at University Of Vermont Medical Center Dialysis South Burlington get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .52 (As Expected) |
| SIR: Upper Confidence Limit | 1.25 |
| SIR: Lower Confidence Limit | .16 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether University Of Vermont Medical Center Dialysis South Burlington's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 103 |
| Transfusion Rate in facility | 18.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 48.2 |
| Transfusion Rate: Lower Confidence Limit | 8.2 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at University Of Vermont Medical Center Dialysis South Burlington lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 600 |
| Mortality Rate in facility | 13.9 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 17.3 |
| Mortality Rate: Lower Confidence Limit | 11.1 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago
University Of Vermont Medical Center Dialysis South Burlington Location: 35 Joy Drive, South Burlington, Vermont, 05403 Phone: (802) 847-3030 |
News Archive
Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.
Group interpersonal psychotherapy is effective in reducing depressive symptoms among adolescent girls affected by war and displacement, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. However, the same treatment was not as effective in boys.
Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.
August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.
› Verified 5 days ago